IDEXX Laboratories Inc (BSP:I1DX34)
R$ 485.25 0 (0%) Market Cap: 200.38 Bil Enterprise Value: 203.82 Bil PE Ratio: 50.45 PB Ratio: 27.53 GF Score: 99/100

IDEXX Laboratories Inc Investor Day 2020 Transcript

Aug 13, 2020 / 02:00PM GMT
Release Date Price: R$305
Jonathan J. Mazelsky
IDEXX Laboratories, Inc. - President, CEO & Director

Good morning, and welcome to IDEXX' 2020 first-ever virtual Investor Day. It's a great example of how we're all adapting to COVID while staying focused on key priorities. I'm Jay Mazelsky, President and CEO of IDEXX, and I'd like to welcome everybody participating through webcast.

We have 2 hours planned for this morning. The first 90 minutes or so will be prepared remarks and presentation. Following a brief 10-minute break, we'll open the session to question and answers. If you have questions during the prepared remarks, all you need to do is hit the Ask Question button in your display viewer. Our Investor Relations team will handle the rest.

I'll be joined this morning by our management team, who will highlight selected topics: Jim Polewaczyk, the Executive Vice President in charge of the Global Commercial Organization, will talk about our commercial strategy. Dr. Tina Hunt, who has responsibility for our Global Point-of-care Diagnostics business and Operations business, will highlight the newest addition

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot